Financialsexperimental
Protalix BioTherapeutics, Inc. (PLX). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.
USD in thousands · shares (whole numbers) · per-share amounts in USD
| Income Statement | Q2 FY26 30 Jun 2026 | Q1 FY26 31 Mar 2026 | Q4 FY25 31 Dec 2025 | Q3 FY25 30 Sept 2025 | Q2 FY25 30 Jun 2025 | Q1 FY25 31 Mar 2025 | Q4 FY24 31 Dec 2024 | Q3 FY24 30 Sept 2024 | Q2 FY24 30 Jun 2024 | Q1 FY24 31 Mar 2024 | Q4 FY23 31 Dec 2023 | Q3 FY23 30 Sept 2023 | Q2 FY23 30 Jun 2023 | Q1 FY23 31 Mar 2023 | Q4 FY22 31 Dec 2022 | Q3 FY22 30 Sept 2022 | Q2 FY22 30 Jun 2022 | Q1 FY22 31 Mar 2022 | Q4 FY21 31 Dec 2021 | Q3 FY21 30 Sept 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL REVENUE | 19,896 | 33,750 | 9,122* | 17,851 | 15,658 | 10,113 | 18,218* | 17,959 | 13,474 | 3,748 | 10,486* | 10,345 | 35,075 | 9,588 | 8,617* | 14,183 | 8,753 | 16,085 | 8,549* | 12,054 |
| COST OF REVENUES | -7,762 | -4,127 | -4,619* | -8,324 | -5,870 | -8,180 | -3,886* | -8,375 | -9,456 | -2,602 | -8,856* | -4,893 | -6,148 | -3,085 | -2,397* | -7,074 | -4,087 | -6,034 | -3,148* | -3,703 |
| RESEARCH AND DEVELOPMENT EXPENSES, NET | -4,351 | -5,426 | -5,635* | -4,467 | -5,992 | -3,475 | -4,124* | -2,998 | -2,961 | -2,887 | -3,102* | -3,669 | -4,475 | -5,847 | -5,617* | -7,386 | -7,579 | -8,767 | -7,641* | -7,282 |
| SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES | -3,111 | -3,051 | -3,526* | -2,929 | -2,624 | -2,603 | -2,999* | -2,595 | -3,484 | -3,115 | -4,143* | -3,670 | -4,031 | -3,115 | -3,098* | -2,848 | -2,611 | -3,154 | -3,466* | -2,954 |
| OPERATING INCOME (LOSS) | 4,672 | 21,146 | -4,658* | 2,131 | 1,172 | -4,145 | 7,209* | 3,991 | -2,427 | -4,856 | -5,615* | -1,887 | 20,421 | -2,459 | -2,495* | -3,125 | -5,524 | -1,870 | -5,706* | -1,885 |
| FINANCIAL EXPENSES | -6 | -6* | -299 | -367 | -390 | -774* | -460 | -1,305 | -649 | -650* | -639 | -623 | -618 | -908* | -2,410 | |||||
| FINANCIAL EXPENSES | -494 | -193 | -383* | -180 | -783 | |||||||||||||||
| FINANCIAL INCOME | 682 | 188 | 265* | 288 | 272 | 419 | 113* | 151 | 522 | 513 | -37* | 628 | 531 | 172 | -65* | 197 | 813 | 202 | -2* | 96 |
| FINANCIAL INCOME (EXPENSES), NET | 188 | -5 | -118* | 108 | -511 | 413 | 107* | -148 | 155 | 123 | -811* | 168 | -774 | -477 | -715* | -442 | 190 | -416 | -910* | -2,314 |
| INCOME (LOSS) BEFORE TAXES ON INCOME | 4,860 | 21,141 | -4,776* | 2,239 | 661 | -3,732 | 7,316* | 3,843 | -2,272 | -4,733 | -6,426* | -1,719 | 19,647 | -2,936 | ||||||
| TAXES ON INCOME | 1,083 | 2,824 | 728* | -116 | 497 | -113 | 822* | 607 | -69 | -138 | -382* | 133 | 308 | 195 | ||||||
| NET INCOME (LOSS) | 3,777 | 18,317 | -5,504* | 2,355 | 164 | -3,619 | 6,494* | 3,236 | -2,203 | -4,595 | -6,044* | -1,852 | 19,339 | -3,131 | -3,740* | -3,567 | -5,334 | -2,286 | -6,667* | -4,199 |
| EARNINGS (LOSS) PER SHARE OF COMMON STOCK - BASIC (in dollars per share) | 0.05 | 0.23 | 0.03 | 0 | -0.05 | 0.04 | -0.03 | -0.06 | -0.03 | 0.29 | -0.05 | -0.07 | -0.11 | -0.05 | -0.09 | |||||
| EARNINGS (LOSS) PER SHARE OF COMMON STOCK - DILUTED (in dollars per share) | 0.05 | 0.22 | 0.03 | 0 | -0.05 | 0.03 | -0.03 | -0.06 | -0.04 | 0.21 | -0.05 | -0.07 | -0.11 | -0.05 | -0.09 | |||||
| WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING EARNINGS (LOSS) PER SHARE - BASIC (in shares) | 79,986,325 | 79,848,892 | 79,281,685 | 78,663,884 | 76,611,980 | 73,549,745 | 73,308,281 | 73,036,569 | 72,281,681 | 67,158,628 | 57,480,009 | 49,498,105 | 47,327,952 | 45,843,563 | 45,556,647 | |||||
| WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING EARNINGS (LOSS) PER SHARE - DILUTED (in shares) | 82,560,235 | 83,048,596 | 80,814,564 | 81,271,610 | 76,611,980 | 81,217,068 | 73,308,281 | 73,036,569 | 83,782,679 | 83,200,641 | 57,480,009 | 49,498,105 | 47,327,952 | 45,843,563 | 45,556,647 | |||||
| TOTAL REVENUE — Product | 19,828 | 7,419 | 8,694* | 17,673 | 15,440 | 9,995 | 18,161* | 17,839 | 13,304 | 3,677 | 10,109* | 10,168 | 15,075 | 5,066 | 4,070* | 8,812 | 3,382 | 9,028 | 4,489* | 4,506 |
| TOTAL REVENUE — License And Service | 68 | 26,331 | 428* | 178 | 218 | 118 | 57* | 120 | 170 | 71 | 377* | 177 | 20,000 | 4,522 | 4,547* | 5,371 | 5,371 | 7,057 | 4,060* | 7,548 |